PLYMOUTH MEETING, PA — INOVIO Pharmaceuticals (NASDAQ: INO) has applied for conditional marketing authorization in Europe for VOCERYQ, its recently approved DNA-based immunotherapy for recurrent respiratory papillomatosis, seeking…

PLYMOUTH MEETING, PA — INOVIO Pharmaceuticals (NASDAQ: INO) has applied for conditional marketing authorization in Europe for VOCERYQ, its recently approved DNA-based immunotherapy for recurrent respiratory papillomatosis, seeking to expand …

Source disclosure

This is a source-linked briefing. Read the original report from Mychesco .